PIH18 Cost-Effectiveness Of 13-Valent Pneumococcal Conjugate Vaccination In Kazakhstan

Simple item page
dc.contributor.authorBektur, C
dc.contributor.authorNurgozhin, T
dc.creatorC, Bektur
dc.date.accessioned2017-12-13T09:45:05Z
dc.date.available2017-12-13T09:45:05Z
dc.date.issued2015-05-01
dc.description.abstractThe aim of the study was to investigate the cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV-13) programme for children in Kazakhstan from the perspective of Ministry of Health.
dc.identifierDOI:10.1016/j.jval.2015.03.624
dc.identifier.citationC Bektur, T Nurgozhin, PIH18 - Cost-Effectiveness Of 13-Valent Pneumococcal Conjugate Vaccination In Kazakhstan, In Value in Health, Volume 18, Issue 3, 2015, Page A106
dc.identifier.issn10983015
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S1098301515006816
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/2877
dc.publisherValue in Health
dc.relation.ispartofValue in Health
dc.rights.licenseCopyright © 2015 Published by Elsevier Inc.
dc.titlePIH18 Cost-Effectiveness Of 13-Valent Pneumococcal Conjugate Vaccination In Kazakhstan
dc.typeArticle
elsevier.aggregationtypeJournal
elsevier.coverdate2015-05-01
elsevier.coverdisplaydateMay 2015
elsevier.identifier.doi10.1016/j.jval.2015.03.624
elsevier.identifier.eid1-s2.0-S1098301515006816
elsevier.identifier.piiS1098-3015(15)00681-6
elsevier.issue.identifier3
elsevier.openaccess1
elsevier.openaccessarticletrue
elsevier.openaccessuserlicensehttp://www.elsevier.com/open-access/userlicense/1.0/
elsevier.openarchivearticletrue
elsevier.startingpageA106
elsevier.volume18

Files

Collections

Center for Life Sciences